[ad_1]
President Joe Biden’s decision not to seek a second term has upended the calculus for this year’s election, market strategists said. It doesn’t appear to be having much of an effect on markets, at least not yet.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...
